{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:51:41Z","timestamp":1769604701350,"version":"3.49.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>We identified 8 pediatric patients on micafungin (MCFG; \u22653 doses) at our institution who had breakthrough candidemia (BC). The causative strains of the BC were <jats:italic toggle=\"yes\">Candida parapsilosis<\/jats:italic> in 7 patients. The minimum inhibitory concentration of MCFG was \u22641 \u00b5g\/mL (susceptible) in all 8 isolates. Immunocompromised patients may develop BC caused by MCFG-susceptible strains.<\/jats:p>","DOI":"10.1097\/inf.0000000000002020","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T14:15:07Z","timestamp":1521728107000},"page":"1258-1260","source":"Crossref","is-referenced-by-count":7,"title":["Breakthrough Candidemia In Children On Micafungin"],"prefix":"10.1097","volume":"37","author":[{"given":"Takanori","family":"Funaki","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Miyairi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan"},{"name":"Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"suppl 6","key":"R2-20230912","doi-asserted-by":"crossref","first-page":"S604","DOI":"10.1093\/cid\/civ814","article-title":"Echinocandins: the expanding antifungal armamentarium.","volume":"61","author":"Aguilar-Zapata","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.bbmt.2010.05.002","article-title":"Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.","volume":"16","author":"Mehta","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/tid.12305","article-title":"Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in Germany.","volume":"16","author":"Heimann","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/JCM.02390-09","article-title":"Breakthrough invasive candidiasis in patients on micafungin.","volume":"48","author":"Pfeiffer","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.01901-07","article-title":"In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jinf.2007.10.014","article-title":"Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.","volume":"56","author":"Forrest","year":"2008","journal-title":"J Infect"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.02163-13","article-title":"Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.","volume":"58","author":"Eschenauer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","article-title":"Resistance to antifungal agents: mechanisms and clinical impact.","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/21505594.2015.1027479","article-title":"Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.","volume":"6","author":"Shirazi","year":"2015","journal-title":"Virulence"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1128\/AAC.00676-07","article-title":"Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species.","volume":"51","author":"Melo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R14-20230912","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MB-0020-2015","article-title":"Candida biofilms: development, architecture, and resistance.","volume":"3","author":"Chandra","year":"2015","journal-title":"Microbiol Spectr"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1128\/AAC.02290-12","article-title":"Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole.","volume":"57","author":"Kaneko","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201812000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:08:57Z","timestamp":1694560137000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201812000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002020","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}